PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection ofinformation unless it contains a valid OMB control number.
`
` .
`
`. Attorney Docket Number|44854-701.104
`
`
`Application Data Sheet 37 CFR 1.76
`
`Application Number
`
`
`
`
`
`
`
`Title of Invention|De Novo Synthesized Gene Libraries
`
`The application data sheetis part of the provisional or nonprovisional application for whichit is being submitted. The following form contains the
`bibliographic data arranged in a format specified by the United States Patent and Trademark Office as outlined in 37 CFR 1.76.
`This document may be completed electronically and submitted to the Office in electronic format using the Electronic Filing System (EFS) or the
`document may be printed and included in a paper filed application.
`
`Secrecy Order 37 CFR 5.2
`Portions or all of the application associated with this Application Data Sheet may fall under a Secrecy Order pursuantto
`L] 37CFR52 (Paperfilers only. Applications that fall under Secrecy Order may not be filed electronically.}
`
`Inventor Information:
`
`
`Inventor
`Legal Name
`
`
`1
`
`Prefix) Given Name
`
`Middle Name
`
`Family Name
`
`William
`Residence Information (Select One)
`(e) US Residency
`©) NonUS Residency
`() Active US Military Service
`
`Suffix
`
`Mailing Addressof Inventor:
`
`Address 1
`
`Address 2
`
`738 Wayland Street
`
`Postal Code
`
`94134
`
`US
`
`2
`Inventor
`
`Legal Name
`
`
`
`Bill
`James
`Peck
`
`Residence Information (Select One)
`(@} US Residency
`©) NonUS Residency
`() Active US Military Service
`
`
`City|Santa Clara State/Province|CA Country of Residence i|US
`
`
`
`Mailing Address of Inventor:
`
`Address 1
`
`Address 2
`
`3086 Carleton Place
`
`City
`
`Santa Clara
`
`Postal Code
`
`95051
`
`State/Province
`
`CA
`
`US
`
`Inventor Information blocks may be
`Inventors Must Be Listed - Additional
`All
`
`generatedwithin this form by selecting the Add button. Ade
`
`CorrespondenceInformation:
`
`Enter either Customer Number or complete the CorrespondenceInformation section below.
`Forfurther information see 37 CFR 1.33(a}.
`
`EFS Web 2.2.6
`
`
`
`
`
`

`

`[] An Addressis being provided for the correspondenceInformation of this application.
`
`
`
`
`Email Address
`
`Add Email
`
`
`
`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Attorney Docket Number|44854-701.101
`
`
`
` Application Data Sheet 37 CFR 1.76
`
` Title of Invention
`De Novo Synthesized Gene Libraries
`
`
`Application Number
`
`Customer Number
`
`021971
`
`
`
`Application Information:
`
`Title of the Invention
`
`De Novo Synthesized Gene Libraries
`
`Attorney Docket Number] 44854701101 Small Entity Status Claimed[|
`Application Type
`Provisional
`
`Total Numberof Drawing Sheets (if any)
`
`Suggested Figure for Publication {if any)
`
`Publication Information:
`
`[] Request Early Publication (Fee required at time of Request 37 CFR 1.219)
`
`[]
`
`Req uest Not to Publish. | hereby request that the attached application not be published under
`35U.S.C. 122(b} and certify that the invention disclosed in the attached application has not and will not be the
`subject of an application filed in another country, or under a multilateral international agreement, that requires
`publication at eighteen monthsafterfiling.
`
`Representative Information:
`
`Representative information should be provided for all practitioners having a power of attorney in the application. Providing
`this information in the Application Data Sheet does not constitute a powerof attomey in the application (see 37 CFR 1.32).
`Either enter Customer Number or complete the Representative Name section below.
`If both sections are completed the customer
`Numberwill be used for the Representative Information during processing.
`
`
`Please Select One: () US Patent Practitioner|() Limited Recognition (37 CFR 11.9)(e) Customer Number
`
`Customer Number
`
`21971
`
`
`
`
`
`
`
`Domestic Benefit/National Stage Information:
`This section allows for the applicant to either claim benefit under 35 U.S.C. 119(e), 120, 121, or 365(c) or indicate
`National Stage entry from a PCT application. Providing this information in the application data sheet constitutes the
`specific reference required by 35 U.S.C. 119(e) or 120, and 37 CFR 1.78.
`
`Application Number
`
`Continuity Type
`
`Prior Application Number
`
`Filing Date (YYYY-MM-DD}
`
`Additional Domestic Benefit/National Stage Data may be generated within this form
`by selecting the Add button.
`
`Add
`
`EFS Web 2.2.6
`
`
`
`

`

`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`oo Attorney Docket Number|44854-701.101
`
`Application Data Sheet 37 CFR 1.76
`—
`
`
`
`Title of Invention|De Novo Synthesized Gene Libraries
`
`Foreign Priority Information:
`
`This section allows for the applicant to claim priority to a foreign application. Providing this information in the application data sheet
`
`constitutes the claim for priority as required by 35 U.S.C. 119{b) and 37 CFR 1.55(d). Whenpriority is claimed to a foreign application
`thatis eligible for retrieval uncer the priority cocument exchange program (PDX) ithe information will be used by the Office to
`automatically attempt retrieval pursuant to 37 CFR 1.55(h){1) and (2). Under the PDX program, applicant bears the ultimate
`responsibility for ensuring that a copy of the foreign application is received by the Office from the participating foreign intellectual
`
`property office, or a certified copy of the foreign priority application is filed, within the time period specified in 37 CFR 1.55(g}{1).
`
`
`Application Number
`Country
`Filing Date (YYYY-MM-DD}
`Access Code (if applicable)
`
`
`
`
`
`
`
`
`
`Additional Foreign Priority Data may be generated within this form by selecting the
`Addbutton.
`
`Add
`
`Statement under 37 CFR 1.55 or 1.78 for AIA (First Inventor to File) Transition
`Applications
`
`16, 2013.
`
`This application (1} claims priority to or the benefit of an application filed before March 16, 2013 and (2) also
`contains, or contained at any time, a claim to a claimed invention that has an effectivefiling date on or after March
`
`[_]
`
`Authorization to Permit Access:
`
`Authorization to Permit Access to the Instant Application by the Participating Offices
`
`If checked, the undersigned hereby grants the USPTO authority to provide the European Patent Office (EPO),
`the Japan Patent Office (JP©), the Korean Intellectual Property Office (KIPO), the World Intellectual Property Office (WIPO),
`and any otherintellectual property offices in which a foreign application claiming priority to the instant patent application
`is filed access to the instant patent application. See 37 CFR 1.14(c) and (h). This box should not be checkedif the applicant
`does not wish the EPO, JPO, KIPO, WIPO, or otherintellectual property office in which a foreign application claiming priority
`to the instant patent application is filed to have accessto the instant patent application.
`
`In accordance with 37 CFR 1.14{h)(3), access will be provided to a copy of the instant patent application with respect
`to: 1) the instant patent application-as-filed: 2) any foreign application to which the instant patent application
`claims priority under 35 U.S.C. 119(a)-(c) if a copy of the foreign application that satisfies the certified copy requirement of
`37 CFR 1.55 has beenfiled in the instant patent application; and 3) any U.S. application-as-filed from which benefit is
`soughtin the instant patent application.
`
`In accordance with 37 CFR 1.14{c), access may be provided to information concerning the date offiling this Authorization.
`
`
`
`EFS Web 2.2.6
`
`
`
`

`

`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Attorney Docket Number|44854-701.101
`Application Data Sheet 37 CFR 1.76
`—
`
`Title of Invention|De Novo Synthesized Gene Libraries
`
` oo
`
`Applicant Information:
`
`Providing assignment information in this section does not substitute for compliance with any requirementof part 3 of Title 37 of CFR
`to have an assignment recorded by the Office.
`
`1
`Applicant
`If the applicant is the inventor (or the remaining joint inventor or inventors under 37 CFR 1.45), this section should not be completed.
`The information to be provided in this section is the name and addressof the legal representative who is the applicant under 37 CFR
`1.43; or the name and addressof the assignee, person to whom theinventoris under an obligation to assign the invention, or person
`who otherwise showssufficient proprietary interest in the matter who is the applicant under 37 CFR 1.46. If the applicantis an
`applicant under 37 CFR 1.46 {assignee, person to whem the inventoris obligated to assign, or person who otherwise showssufficient
`proprietary interest) together with one or morejoint inventors, then the joint inventor or inventors who are also the applicant should be
`identified in this section.
`
`(e) Assignee
`
`Joint Inventor
`
`C) Legal Representative under 35 U.S.C. 117
`
`©)
`
`
`
`OQ Person to whom theinventoris obligated to assign. O Person who shows sufficient proprietary interest
`
`
`
`
`
`lf applicant is the legal representative, indicate the authority to file the patent application, the inventor is:
`
`Nameof the Deceased or Legally Incapacitated Inventorfo
`
`If the Applicant is an Organization check here.
`Organization Name
`Twist Bioscience Corporation
`
`Mailing Address Information:
`
`Address 1
`
`Address 2
`
`974 Rhode Island Street
`
`Additional Applicant Data may be generated within this form by selecting the Add button.
`
`Add
`
`Email Address
`
`Non-Applicant Assignee Information:
`
`have an assignmentrecordedby the Office.
`
`Providing assignment information in this section does not subsitute for compliance with any requirementof part 3 of Title 37 of CFR to
`
`EFS Web 2.2.6
`
`

`

`PTO/AIA/14 (03-13)
`Approved for use through 01/31/2014. OMB 0651-0032
`U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
`Underthe Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number.
`
`Attorney Docket Number|44854-701.101
`
`
`
` Application Data Sheet 37 CFR 1.76
`
`Title of Invention
`De Novo Synthesized Gene Libraries
`
`
`Application Number
`
`Assignee
`
`1
`
`Complete this section only if non-applicant assignee information is desired to be included on the patent application publication in
`accordance with 37 CFR 1.215{b). Do not include in this section an applicant under 37 CFR 1.46 (assignee, person to whom the
`inventor is obligated to assign, or person who ctherwise showssufficient proprietary interest}, as the patent application publication will
`include the name of the applicant(s).
`Remove
`
`If the Assignee is an Organization check here.
`
`
`Prefix
`
`Middle Name
`
`Family Name
`
`Suffix
`
`Mailing Address Information:
`
`Address 2
`
`
`Address 1
`
`City
`
`State/Province
`
`Additional Assignee Data may be generated within this form by selecting the Add button.
`
`Add
`
`Signature:
`
`NOTE: This form must be signed in accordance with 37 CFR 1.33. See 37 CFR 1.4 for signature requirements and
`certifications
`
`
`
`
`
`
`
`
`|/PINAR BAILEY/ Date (YYYY-MM-DD}|Signature 2013-08-05
`
`
`First Name Registration Number|71605F. Pinar Last Name Bailey
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Add
`Additional Signature may be generated within this form by selecting the Add button.
`
`
`This collection of information is required by 37 CFR 1.76. The information is required to obtain or retain a benefit by the public which
`is to file (and by the USPTOto process) an application. Confidentiality is governed by 35 U.S.C. 122 and 3/7 CFR 1.14. This
`collection is estimated to take 23 minutes to complete, including gathering, preparing, and submitting the completed application data
`sheet form to the USPTO. Time will vary depending upon the individual case. Any comments on the amountof time you require to
`complete this form and/or suggestions for reducing this burden, should be sent to the Chief Information Officer, U.S. Patent and
`Trademark Office, U.S. Department of Commerce, P.O. Box 1450, Alexandria, VA 22313-1450. DO NOT SEND FEES OR
`COMPLETED FORMS TO THIS ADDRESS. SEND TO: Commissionerfor Patents, P.O. Box 1450, Alexandria, VA 22313-1450.
`
`EFS Web 2.2.6
`
`

`

`Privacy Act Statement
`
`The information provided by you in this form will be subject to the following routine uses:
`
`1.
`
`The information on this form will be treated confidentially to the extent allowed under the Freedom of Information Act (5 U.S.C. 552)
`and the Privacy Act (5 U.S.C. 552a). Records from this system of records may be disclosed to the Department of Justice to determine
`whether the Freedom cofInformation Act requires disclosure of these records.
`
`A record from this system of records may be disclosed, as a routine use, in the course of presenting evidence to a court, magistrate, or
`administrative tribunal, including disclosures to opposing counsel in the course of settlement negotiations.
`
`A record in this system of records may be disclosed, as a routine use, to a Member of Congress submitting a request involving an
`individual, to whom the record pertains, when the individual has requested assistance from the Member with respect to the subject matter of
`the record.
`
`A record in this system of records may be disclosed, as a routine use, to a contractor of the Agency having need for the information in
`order to perform a contract. Recipients of information shall be required to comply with the requirements of the Privacy Act of 1974, as
`amended, pursuant to 5 U.S.C. 552a(m).
`
`A record related to an International Application filed under the Patent Cooperation Treaty in this system of records may be disclosed,
`as a routine use, to the International Bureau of the World Intellectual Property Organization, pursuant to the Patent Cooperation Treaty.
`
`A record in this system of records may be disclosed, as a routine use, to another federal agency for purposes of National Security
`review (35 U.S.C. 181} and for review pursuant to the Atomic Energy Act (42 U.S.C. 218(c)).
`
`A record from this system of records may be disclosed, as a routine use, to the Administrator, General Services, or his/her designee,
`during an inspection of records conducted by GSA aspart of that agency's responsibility to recommend improvements in records
`management practices and programs, under authority of 44 U.S.C. 29804 and 2906. Such disclosure shall be made in accordance with the
`GSA regulations governing inspection of records for this purpose, and any other relevant(i.e., GSA or Commerce) directive. Such
`disclosure shall not be used to make determinations aboutindividuals.
`
`
`
`(1) the general authority for the collection
`a patent application or patent. Accordingly, pursuant to the requirements of the Act, please be advised that:
`of this information is 35 U.S.C. 2(b)(2); (2) furnishing of the information sclicited is voluntary; and (3) the principal purpose for which the information is
`used by the U.S. Patent and Trademark Office is to process and/or examine your submission related to a patent application or patent.
`If you do not
`furnish the requested information, the U.S. Patent and Trademark Office may not be able to process and/or examine your submission, which may
`result in termination of proceedings or abandonmentof the application or expiration of the patent.
`
` The Privacy Act of 1974 (P.L. 93-579) requires that you be given certain information in connection with your submission of the attached form related to
`
`A record from this system of records may be disclosed, as a routine use, to the public after either publication of the application pursuant
`to 35 U.S.C. 122(b) or issuance of a patent pursuant to 35 U.S.C. 151. Further, a record may be disclosed, subject to the limitations of 37
`CFR 1.14, as a routine use, to the public if the record wasfiled in an application which became abandonedorin which the proceedings were
`terminated and which application is referenced by either a published application, an application open to public inspections or an issued
`patent.
`
`A record from this system of records may be disclosed, as a routine use, to a Federal, State, or local law enforcement agency,if the
`USPTO becomes awareof a violation or potential violation of law or regulation.
`
`
`EFS Web 2.2.6
`
`